Movano Inc (MOVE) Stock Price, Quote & News

Latest News on MOVE

Apr 22, 2025, 8:00 AM EDT - 6 days ago

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

Mar 10, 2025, 8:00 AM EDT - 7 weeks ago

Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey

Feb 4, 2025, 8:00 AM EST - 2 months ago

Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device

Jan 8, 2025, 8:00 AM EST - 3 months ago

Movano Health Launches EvieAI Virtual Wellness Assistant

Jan 2, 2025, 8:00 AM EST - 4 months ago

Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors

Dec 2, 2024, 9:22 AM EST - 5 months ago

Movano Health Receives FDA Clearance for EvieMED Ring

Nov 14, 2024, 9:57 PM EST - 5 months ago

Movano Inc. (MOVE) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:05 PM EST - 5 months ago

Movano Health Reports Q3 2024 Financial Results and Provides Business Update

Nov 7, 2024, 8:00 AM EST - 6 months ago

Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device

Nov 6, 2024, 8:00 AM EST - 6 months ago

Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024

Nov 4, 2024, 8:00 AM EST - 6 months ago

Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Nov 4, 2024, 8:00 AM EST - 6 months ago

Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

Oct 31, 2024, 8:30 AM EDT - 6 months ago

Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Oct 30, 2024, 9:00 AM EDT - 6 months ago

Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio

Oct 25, 2024, 9:00 AM EDT - 6 months ago

Movano Health Announces Reverse Stock Split

Oct 24, 2024, 8:00 AM EDT - 6 months ago

Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase

Oct 10, 2024, 8:00 AM EDT - 7 months ago

Movano Health Provides Update on FDA Review of EvieMED Ring

Sep 17, 2024, 8:00 AM EDT - 7 months ago

Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades

Sep 3, 2024, 8:00 AM EDT - 8 months ago

Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

Aug 14, 2024, 7:38 PM EDT - 9 months ago

Movano Inc. (MOVE) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 9 months ago

Movano Health Reports Q2 2024 Financial Results and Provides Business Update

Aug 5, 2024, 9:00 AM EDT - 9 months ago

Movano Health Provides Progress Update on EvieMED Regulatory Filing

Aug 5, 2024, 9:00 AM EDT - 9 months ago

Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024

Jun 28, 2024, 9:00 AM EDT - 10 months ago

Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event

Jun 13, 2024, 9:00 AM EDT - 11 months ago

Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion

Jun 10, 2024, 9:00 AM EDT - 11 months ago

MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease

May 15, 2024, 7:05 PM EDT - 1 year ago

Movano Inc. (MOVE) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:05 PM EDT - 1 year ago

Movano Health Reports Q1 2024 Financial Results and Provides Business Update

May 9, 2024, 8:00 AM EDT - 1 year ago

Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision

May 6, 2024, 5:00 PM EDT - 1 year ago

Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024

Apr 10, 2024, 10:23 AM EDT - 1 year ago

Movano Inc. (MOVE) Q4 2023 Earnings Call Transcript

Apr 5, 2024, 8:00 AM EDT - 1 year ago

Movano Health Closes $24 Million Private Placement

Apr 4, 2024, 4:30 PM EDT - 1 year ago

Movano Health Reports 2023 Financial Results and Provides Business Update

Apr 2, 2024, 5:01 PM EDT - 1 year ago

Movano Health Announces $24 Million Private Placement

Apr 2, 2024, 5:00 PM EDT - 1 year ago

Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company

Apr 2, 2024, 4:05 PM EDT - 1 year ago

Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024

Jan 22, 2024, 8:00 AM EST - 1 year ago

Movano Health Announces Evie Rings Now Shipping

Jan 9, 2024, 8:00 AM EST - 1 year ago

Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women

Jan 8, 2024, 7:00 AM EST - 1 year ago

Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level

Dec 18, 2023, 8:00 AM EST - 1 year ago

Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring

Dec 12, 2023, 12:00 PM EST - 1 year ago

Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement

Nov 29, 2023, 8:00 AM EST - 1 year ago

Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement

Nov 20, 2023, 8:00 AM EST - 1 year ago

Evie, the Smart Ring for Women from Movano Health, Available for Order Today

Nov 17, 2023, 10:09 AM EST - 1 year ago

Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option

Nov 15, 2023, 5:25 PM EST - 1 year ago

Movano Inc. (MOVE) Q3 2023 Earnings Call Transcript

Nov 15, 2023, 6:02 AM EST - 1 year ago

Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results

Nov 15, 2023, 6:00 AM EST - 1 year ago

Movano Health Prices $3.6 Million Public Offering

Nov 14, 2023, 4:15 PM EST - 1 year ago

Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023

Nov 14, 2023, 4:06 PM EST - 1 year ago

Movano Health Announces Proposed Public Offering

Nov 3, 2023, 4:05 PM EDT - 1 year ago

Market Cap	8.80M
Revenue (ttm)	1.01M
Net Income (ttm)	-23.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,349.50%
Debt to Equity Ratio	0.00

Volume	27,256
Avg Vol	28,344
Day's Range	N/A - N/A
Shares Out	7.04M
Stochastic %K	21%
Beta	0.88
Analysts	Sell
Price Target	$29.98